Next Level Wealth Planning’s Gilead Sciences GILD Stock Holding History

Next Level Wealth Planning’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.83K	Buy	+19	New	+$2.67K	﹤0.01%	433

Other funds holding GILD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Next Level Wealth Planning's GILD Position: Q3 2026 in Review

Next Level Wealth Planning opened a new position in Gilead Sciences (GILD) in Q3 2026: 19 shares worth $2.83K. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings.

1,465 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Next Level Wealth Planning held 19 shares of Gilead Sciences worth $2.83K as of Q3 2026.
Gilead Sciences was a new Next Level Wealth Planning position in Q3 2026.
Gilead Sciences made up ﹤0.01% of Next Level Wealth Planning's portfolio in Q3 2026, its #433 holding.
1,465 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Next Level Wealth Planning's 13F filing for Q3 2026, filed 29 Oct 2026.